Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

NCT00603538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: CP-751,871 + carboplatin + paclitaxel

Sponsor

Pfizer